Latest Conference Articles

Recent studies have revealed clues to the role played by the gut microbiome in a variety of diseases and conditions. Now researchers are looking at whether aberrant immune responses triggered by disruptions in the gut microbiome are to blame for multiple sclerosis.

Patients with chronic obstructive pulmonary disease who use inhaled corticosteroids have a decreased risk of dying from pneumonia, but face an increased risk of contracting the infection.

Researchers at ATS 2015 reported chronic obstructive pulmonary disease was a risk factor for cardiovascular disease, but was not independently linked to risk of stroke or systemic embolism.

Patients with a range of pain conditions may face amplified discomfort based how on how they perceive their symptoms. The findings were presented at the 34th Annual American Pain Society Scientific Meeting in Palm Springs, CA.

With the help of a 3-D printer researchers are working on developing a new overtube that can be used during endoscopic submucosal dissection.

In most cases when a patient undergoes a biopsy on their esophagus any cancer found is located too late to be treated. A recent development could help doctors find the disease before it is too late.

While there have been some concerns raised about computer assisted propofol sedation studies have shown it to be a safe and effective method when conducted by properly trained healthcare professionals. Work is also being done to ensure better results in the future.

According to research done on computer assisted propofol sedation patients see a faster recovery time by approximately 6 minutes on average. This can help not only the patients to leave the recovery area faster, but can also put less of a burden on the staff and location of their endoscopic procedure.

When undergoing endoscopic procedures it is important that patients receive the proper pain medication. A recent study looked at whether a computer can assist in the process to keep the patients comfortable allow them to continue on their day after the procedure.

Implanting an electrical stimulating device to help patients with gastroparesis is less successful when patients also suffer from depression, anxiety, or other mental health problems, a Texas team reports.

For patients with severe and life threatening allergies epinephrine auto injectors can provide the right dose to help them work through an emergency situation. There are now new models available that can help talk patients through the process and fit better to the injection site.

With the weather getting warmer stinging insects like bees and wasps are becoming more of a concern for people with allergies or potential allergies. How these conditions are treated can make a significant difference in the time following stings.

If previous research has shown a correlation between chronic pain and depression, it's only natural that the same can be said about chronic pain and happiness – right? A new study shows that's not the case.

Obesity associated with metabolic syndrome can be treated when patients adhere to a high-protein diet, a team of researchers from University of California, Los Angeles found.

Food allergies are an ever growing concern for doctors in a wide range of specialties and now there are new conditions for them to consider when looking to make a proper diagnosis.

There are medications which can all but cure hepatitis C but for those patients who have not yet beaten the condition there is research that shows a link to developing cancer.

As work continues to be done to find the best ways to use new technology the question of what the next advancement will be is already setting the stage for the future of patient care.

Patients with long-standing ulcerative colitis have shown signs of being more at risk for developing cancer. Research has looked at why that is the case and what can be done to prevent the cancer from progressing.

Patients with gastroparesis may be helped with a combination of gastric electrical stimulation and surgery to widen the pylorus, a Texas team reports.

Gastroenterologist Venkat Subramanian, MD, discusses the use of high-definition screens and dyes during endoscopy to detect cancerous and noncancerous lesions in patients with ulcerative colitis

Patients who are obese may have a genetic makeup that causes their stomachs to empty faster than those of normal-weight people. Investigators say there is a drug that can help.

Opioid addiction is a serious problem that a subset of patients prescribed opioids for pain could face; however, the issue presents an even more slippery slope for those with chronic pain due to the long-term need for the drugs.

Treating hepatitis C with new antivirals saves lives and-in the long run-money spent on patient care. But some patients and their physicians are learning there are barriers to getting prescriptions approved by patients' insurance carriers.

Antony Loebel, MD, Executive Vice President and Chief Medical Officer, Sunovion Pharmaceuticals Inc. provided invaluable insight on the first placebo-controlled trial for patients with Major Depressive Disorder with mixed features.

Patients' levels of anxiety and defensiveness are associated with how they view their chronic back pain, a new study showed.

African Americans are more likely to be infected with the hepatitis C virus than Caucasians. But that does not mean they are more likely to die from the disease, researchers reported at the 2015 Digestive Disease Week conference in Washington, DC.

A relatively higher rate of hepatitis C infection in US adults considered to be part of the baby boom generation is starting to decline, researchers report. The statistical drop started the year after a CDC push for all US adults to get tested.

A recent study found that while most insurers are paying for the new hepatitis C antivirals, disparities exist. More than 20% of patients at the hospital studied who had private insurance were refused their prescriptions for sofosbuvir with simeprevir, the researchers found.

A drug that shows promise in protecting the human gut microbiome from antiobiotic assaults that can lead to C. difficile infection is about to enter Phase 2 trials. So far, it has worked well in lab pigs, researchers said at Digestive Disease Week 2015.